Offerings // Armata Pharmaceuticals, Inc.

ARMP offering history

Every offering-related filing in Armata Pharmaceuticals, Inc.’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 1,000 filings back to Jan 13, 2004.

Last executed offering

Dec 1, 2025

424B5 — priced deal (shares or notes)

Last registration (announced)

Aug 13, 2025

S-3 — capacity, not a sale

Executed, last 12 months

424B pricings + 8-K 3.02 sales

Registered, last 12 months

S-1/S-3/F-series registrations

Date	Filing		What it means
Dec 1, 2025	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Aug 22, 2025	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Aug 13, 2025	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Apr 6, 2023	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Apr 6, 2023	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Mar 28, 2023	S-3/A →	REGISTERED	S-3/A registration — capacity to sell shares, not a sale yet
Feb 13, 2023	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Jan 10, 2023	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Jun 1, 2022	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
May 31, 2022	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
May 24, 2022	S-3/A →	REGISTERED	S-3/A registration — capacity to sell shares, not a sale yet
May 16, 2022	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Apr 6, 2022	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Apr 6, 2022	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Mar 31, 2022	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Mar 29, 2022	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Feb 11, 2022	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Oct 29, 2021	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
May 20, 2021	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
May 20, 2021	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
May 13, 2021	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Mar 17, 2021	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Jan 27, 2021	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Apr 9, 2020	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Apr 9, 2020	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Apr 8, 2020	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Apr 8, 2020	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Apr 1, 2020	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Apr 1, 2020	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Mar 30, 2020	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Feb 13, 2020	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Jan 30, 2020	RW →	WITHDRAWN	Registration withdrawn
Jan 29, 2020	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Jan 9, 2020	S-1/A →	REGISTERED	S-1/A registration — capacity to sell shares, not a sale yet
Jan 9, 2020	FWP →	MARKETING	Free-writing prospectus — offering being marketed
Dec 20, 2019	S-1 →	REGISTERED	S-1 registration — capacity to sell shares, not a sale yet
May 10, 2019	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Feb 7, 2019	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Oct 15, 2018	424B4 →	EXECUTED	Final prospectus — offering priced (typical for IPOs and marketed share deals)
Oct 11, 2018	S-1/A →	REGISTERED	S-1/A registration — capacity to sell shares, not a sale yet

ARMP offering-related filings from SEC EDGAR, newest first (capped at 40). Each links to the original document.

Two honest limits. (1) A 424B takedown can price shares or notes— EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.

Is a shelf active now? →Do they need money? →Red flags →Full ARMP workspace →

ARMP offering FAQ

When did ARMP last execute an offering?

Per SEC filings, Armata Pharmaceuticals, Inc.'s most recent priced offering document is a 424B5 filed 2025-12-01. Note a 424B takedown can price shares or notes (debt) — the linked document says which.

When did ARMP last announce or register an offering?

The most recent registration is a S-3 filed 2025-08-13. A registration is capacity to sell shares — not a sale.

Does an offering always mean dilution?

Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.